NIBRT is Hiring

Exciting Career Opportunities in NIBRT 2022

NIBRT is expanding with ambitious plans for 2022 including building a new Cell and Gene Research & Training Facility and launching a number of innovative research projects.

NIBRT are looking to hire talented and passionate scientists with an interest in working at the cutting edge of biopharmaceutical manufacturing research. We are currently hiring across multiple roles including Principal Investigators, Research Fellows, Postdoctoral Researchers and Research Assistants.  

Our Upcoming Research Projects

Professor Niall Barron will hire talented scientists with experience in Immunology, T cell isolation, manipulation and analysis, strong flow cytometry expertise, experience with cell-based assays, strong cell/molecular biology background to work on his project entilted ‘Development of a high-throughput cell engineering system for application in cell therapy’. It is a collaboration with Avectas and Bluebridge Technologies, to advance the development of a novel device for delivering DNA/RNA/protein into large numbers of cells in vitro for applications such as modified T cell therapy (CAR-T).

Professor Barron also will be conducting a research study on the ‘Development and implementation of a versatile genome-editing platform for cell line improvement during recombinant protein production’ with another industrial partner. Scientists with experience in in vitro suspension cell culture andmolecular biology expertise, including nucleic acid manipulation and analysis, cell transfection, flow cytometry, single cell cloning, next generation sequencing (library prep) and protein analysis/quantification, are invited to apply.

Dr Jonathan Bones will be undertaking multiple exciting research projects with a number of academic and industrial partners predominately in the areas of advanced characterisation of biopharmaceuticals and development of new approaches for process analytical technologies (PAT). He will hire scientists with experience in mAbs, including perfusion/continuous experience, and cell therapy, in particular CAR-T workflows.

Professor Michael Butler has opportunities in an active Cell Technology group for appointments at Post-doctoral and Research Assistant research level.   This includes the monitoring and control of mammalian cells using advanced optical and dielectric methods that identify critical metabolic stages of bioprocesses.  Projects are also available for the design of cell culture media to maximise productivity of recombinant proteins including monoclonal antibodies.   Glycosylation is also a key area of interest of the group with the possibilities of enhancing the therapeutic activity of antibodies by re-structuring glycan profiles.   All positions involve collaboration with industrial companies and would suit applicants with experience in Chemical Engineering, Chemistry, Biochemistry or Life Sciences and with an interest in research in cell technology.

Dr Colin Clarke is immediately seeking a Research Fellow in Bioinformatics, focussed on the application of cutting-edge single cell analysis methods to accelerate the delivery of biological medicines.  The focus will be on the manufacturing of chimeric antigen receptor (CAR) T-cell therapies, funded under the ‘Disruptive Technologies Innovation Fund’.

Our terms, conditions and working environment:-

  • Fully subsidised Private Health Insurance cover for all staff members
  • Enhanced Maternity and Paternity Leave policies, providing full salary throughout periods of leave
  • A Flexible Hybrid Working model allowing new and increased flexibilities to where and when we work
  • All employees will be provided with full home office setup including laptop to support our Hybrid Working model
  • Life Assurance and Income Protection Insurance
  • Enhanced security of Research/Grant funded contracts of employment
  • A NIBRT Seed Funding Grant Programme with constant peer review to support early-stage researchers who wish to become independent researchers

We are enhancing our facility, offices and social spaces to allow for more research collaboration and connection with each other, leaving the turbulent times of 2020 and 2021 behind us and looking to a bright future.

If working with NIBRT sounds appealing to you or to someone you know, drop in for a coffee and a chat, send us an email,  forward this message or direct anyone you think would be interested in a role with us to our website to find out more